Building a S.M.A.R.T. Biomarker Strategy Webinar скачать в хорошем качестве

Building a S.M.A.R.T. Biomarker Strategy Webinar

Building a S.M.A.R.T. Biomarker Strategy: A Mechanism-Driven Approach that Predicts Clinical Success Overview: Many modern therapies, particularly in oncology and immunology, work within complex tissue environments where target expression, pathway activation, immune context, and cellular interactions together determine therapeutic response. Yet biomarker strategies are often built from fragmented assays that measure isolated signals without capturing how biology functions at the tissue and cellular level. As a result, biomarkers are frequently difficult to translate, difficult to interpret, and ultimately insufficient to guide clinical decisions. This contributes to late-stage clinical failures driven by lack of efficacy or incomplete biological understanding. Learn how to build a successful biomarker strategy that results in: • Early validation of target relevance and mechanism of action (MoA) • Understanding of cell-type specificity, tissue heterogeneity and biological context • Identification of translational biomarkers that remain meaningful from preclinical to clinical stages • Strong rationale for biomarker down-selection prior to formal validation • Confidence in biomarker data used to support development decisions • Prevention of unanticipated late clinical failure caused by lack of efficacy Don’t be blindsided by your clinical results after investing years of development. Join biomarker experts, Dr. David Bonnel and Dr. Corinne Ramos, to learn how to build a mechanism-driven biomarker strategy that equips you with critical decision-making data from the start.